The study examines actigraphic, observational, psychometric and associated repeated measurements obtained prior to and during psychopharmacological treatment.
Baseline actigraphic measurements, multi-symptom operationally defined observations and psychometric data will be established and repeated to measure treatment response. Additional biological and biometric measures that have potential to further characterize the cohorts under study or treatment response will be collected as practical and when possible.
Study Type
OBSERVATIONAL
Enrollment
44
This study will include those anticipating or receiving any pharmacological intervention
Child Psychopharmacology Institute
Fargo, North Dakota, United States
Actigraphic Measurement
Actigraphic measurements are recorded every 30 seconds during three week measurement periods. The actigraphic measurements will be made utilizing an Actiwatch (AW-64 Phillips-Rispironics, Inc.), placed on the subject's non-dominant wrist. The measurements will occur every thirty seconds for approximately 21 consecutive days. Actigraphic measurements collected at this frequency reflect circadian patterns of interest; discern sleep states and characterize activity and activity patterns.
Time frame: Three week actigraphic measurement periods
Operationally Defined Observations
The Systematic Observation Scale™ utilizes operationally defined symptoms that are presented to the primary observer (self or parent) for determination regarding the percentage of time symptoms are present. Target symptoms will be defined at baseline. Systematic Observation Scale measurements will be obtained at baseline and weekly post-treatment for periods defined as treatment initiation, treatment adjustment or treatment-course longitudinal.
Time frame: Randomly repeated treatment course observational measurements during actigraphic measurement periods
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.